Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Sun Pharmaceutical Industries Ltd.
483
•Sun Pharmaceutical Industries Ltd.•June 13, 2025

Sun Pharmaceutical Industries Ltd. – FDA 483, Jun 13, 2025

Record Details

Medi-Fare Drug Pharmaceutical Compounding, LLC, located in Blacksburg, SC, underwent an FDA inspection from May 19 to June 6, 2025. The inspection revealed several critical violations in their sterile drug manufacturing processes. Key issues included inadequate procedures to prevent microbiological contamination, as evidenced by contaminated HEPA filters and insufficient personnel training for detecting failing units. The facility also failed to maintain aseptic conditions, with residues and stains observed in ISO 5 hoods and inadequate cleaning and sanitizing procedures.

The inspection noted deficiencies in the design of the facility, which allowed material flow between unclassified and classified areas without proper monitoring of differential pressures. Alarm systems for air pressure differentials were not scientifically established or monitored. Environmental and personnel monitoring during aseptic processing were found lacking, with non-viable particle monitoring not performed continuously.

Additionally, the company relied on supplier certificates of analysis without validating the reliability of these reports, particularly concerning the sterility of water used in drug production. Investigations into batch failures were incomplete, lacking documented conclusions and follow-up actions. The stability testing program was discontinued in 2018, yet production of various drug products continued without determining appropriate expiration dates.

The FDA requires Medi-Fare Drug Pharmaceutical Compounding, LLC to address these deficiencies by establishing and following scientifically sound procedures, ensuring proper training, validating supplier reports, and reinstating stability testing to ensure compliance with regulatory standards.

Company
Sun Pharmaceutical Industries Ltd.
Inspection date
June 13, 2025
Product type
Drugs
Office
Food and Drug Administration
People
  • Pratik S. Upadhyay
  • Justin A. Boyd (Research Specialist II)
  • Lisa L. Flores (Consumer Safety Officer/ Federal Investigator)
View Company Profile

ID · 6b9dfb21-fd85-4f32-a4fe-4c572986ff4e

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sun Pharmaceutical Industries Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.